{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:23:30Z","timestamp":1765545810540},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.prostaglandins.2013.01.004","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T03:59:32Z","timestamp":1360036772000},"page":"72-78","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine"],"prefix":"10.1016","volume":"106","author":[{"given":"Helena","family":"Domeij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"B\u00e4cklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna G.","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Z.","family":"Haeggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Mod\u00e9er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cardiores.2005.11.003","article-title":"Atherosclerosis and proteinase activation","volume":"69","author":"Dollery","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"21","key":"10.1016\/j.prostaglandins.2013.01.004_bib0015","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0602414103","article-title":"Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability","volume":"103","author":"Qiu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.prostaglandins.2013.01.004_bib0020","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem Rev"},{"issue":"11","key":"10.1016\/j.prostaglandins.2013.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.prostaglandins.2013.01.004_bib0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.prostaglandins.2013.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI114562","article-title":"Minimally modified low density lipoprotein stimulates monocyte endothelial interactions","volume":"85","author":"Berliner","year":"1990","journal-title":"J Clin Invest"},{"issue":"2\u20133","key":"10.1016\/j.prostaglandins.2013.01.004_bib0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0021-9150(91)90106-D","article-title":"Biologically modified LDL increases the adhesive properties of endothelial cells","volume":"90","author":"Frostegard","year":"1991","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1073\/pnas.87.3.904","article-title":"Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937","volume":"87","author":"Frostegard","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.prostaglandins.2013.01.004_bib0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.12.4.461","article-title":"Induction of T-cell activation by oxidized low density lipoprotein","volume":"12","author":"Frostegard","year":"1992","journal-title":"Arterioscler Thromb"},{"issue":"8","key":"10.1016\/j.prostaglandins.2013.01.004_bib0055","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis","volume":"85","author":"Quinn","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.prostaglandins.2013.01.004_bib0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2249.1999.00871.x","article-title":"Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism","volume":"116","author":"Huang","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2013.01.004_bib0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.17.5.963","article-title":"Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism","volume":"17","author":"Frostegard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.prostaglandins.2013.01.004_bib0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2005.10.007","article-title":"Annexin A5 in cardiovascular disease and systemic lupus erythematosus","volume":"210","author":"Cederholm","year":"2005","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.ATV.0000150415.18759.36","article-title":"Decreased binding of Annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus","volume":"25","author":"Cederholm","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/03009740903124432","article-title":"Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease","volume":"39","author":"Frostegard","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/ATVBAHA.110.216747","article-title":"Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice","volume":"31","author":"Ewing","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI25074","article-title":"Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice","volume":"116","author":"Gough","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.106.619056","article-title":"Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo","volume":"114","author":"Deguchi","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2013.01.004_bib0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0765.2005.00840.x","article-title":"Cell interactions between human gingival fibroblasts and monocytes stimulate the production of matrix metalloproteinase-1 in gingival fibroblasts","volume":"41","author":"Domeij","year":"2006","journal-title":"J Periodontal Res"},{"issue":"8","key":"10.1016\/j.prostaglandins.2013.01.004_bib0105","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.CIR.99.8.993","article-title":"Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages","volume":"99","author":"Xu","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.prostaglandins.2013.01.004_bib0110","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1161\/01.CIR.96.7.2339","article-title":"Inhibition of arterial thrombosis by recombinant Annexin V in a rabbit carotid artery injury model","volume":"96","author":"Thiagarajan","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1160\/TH06-07-0381","article-title":"Recombinant Annexin-2 inhibits the progress of diabetic nephropathy in a diabetic mouse model via recovery of hypercoagulability","volume":"97","author":"Ishii","year":"2007","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31815b60a1","article-title":"The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke","volume":"336","author":"Ding","year":"2008","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.prostaglandins.2013.01.004_bib0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/qjmed\/hcn088","article-title":"Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men","volume":"101","author":"Welsh","year":"2008","journal-title":"Q J Med"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.04.045","article-title":"Markers of inflammation and coronary artery calcification: a systematic review","volume":"201","author":"Hamirani","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI8768","article-title":"Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction","volume":"106","author":"Ducharme","year":"2000","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.prostaglandins.2013.01.004_bib0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/13459","article-title":"Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure","volume":"5","author":"Heymans","year":"1999","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2004-08-3323","article-title":"Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase","volume":"106","author":"Serezani","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.prostaglandins.2013.01.004_bib0155","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1096\/fj.06-7974com","article-title":"Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses","volume":"21","author":"Wan","year":"2007","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.prostaglandins.2013.01.004_bib0160","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni972","article-title":"Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues","volume":"4","author":"Goodarzi","year":"2003","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.prostaglandins.2013.01.004_bib0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrd1796","article-title":"Leukotriene modifiers as potential therapeutics for cardiovascular disease","volume":"4","author":"Funk","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng1692","article-title":"A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction","volume":"38","author":"Helgadottir","year":"2006","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng1311","article-title":"The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke","volume":"36","author":"Helgadottir","year":"2004","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.prostaglandins.2013.01.004_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0185","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.242716099","article-title":"Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis","volume":"100","author":"Spanbroek","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.prostaglandins.2013.01.004_bib0190","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/CVI.13.5.575-583.2006","article-title":"Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN","volume":"13","author":"Itou","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.prostaglandins.2013.01.004_bib0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/srep00139","article-title":"A phospholipidomic analysis of all defined human plasma lipoproteins","volume":"1","author":"Dashti","year":"2012","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.prostaglandins.2013.01.004_bib0200","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","article-title":"Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay","volume":"163","author":"Rand","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2013.01.004_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","article-title":"Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism","volume":"34","author":"de Faire","year":"2010","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.prostaglandins.2013.01.004_bib0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10616-010-9290-0","article-title":"Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-OxLDL uptake","volume":"62","author":"Xu","year":"2010","journal-title":"Cytotechnology"},{"issue":"8","key":"10.1016\/j.prostaglandins.2013.01.004_bib0215","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice","volume":"105","author":"Febbraio","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882313000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882313000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T07:20:26Z","timestamp":1562656826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882313000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":43,"alternative-id":["S1098882313000051"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2013.01.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}